查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1804305

生物感应器的全球市场:各类型，各产品类型，各技术，各用途，各终端用户，各地区 - 市场规模，产业趋势，机会分析，预测(2025年～2033年)

Global Biosensors Market: By Type, Product Type, Technology, Application, End Users, Region- Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033
出版日期: | 出版商: Astute Analytica | 英文 342 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球生物感测器市场正经历重大转型期，这得益于技术进步和应用领域的不断拓展，包括医疗保健、环境监测、农业和食品安全。预计该市场规模将在2024年达到321.5亿美元，到2033年将达到758.4亿美元，2025年至2033年间的复合年增长率将达到10.40%。

生物感测器在应对日益加重的慢性病负担方面发挥关键作用。全球糖尿病患者超过4.22亿，持续血糖监测系统已成为标准配置，其中雅培的FreeStyle Libre系统最为领先，在美国拥有400万用户。同样，能够在几分钟内检测出心臟生物标记的生物感测器正在彻底改变心血管应用，从而加速治疗和诊断。美国已有5800万用户采用了整合生物感测器的可穿戴设备，改善了紧急应变和患者预后。同时，与2020年相比，成本降低了35%，并且与智慧型手机相容，使生物感测器技术更加普及。

除了医疗保健领域，生物感测器还在推进环境安全，可在几秒钟内检测出水污染物，并在食品安全方面取得进展，能够在15分钟内快速识别病原体。石墨烯奈米感测器和人工智慧诊断等技术创新正在提高各个领域的准确性、速度和整合能力。

值得关注的市场发展

  • Biolinq在C轮融资中筹集了1亿美元，用于推进多分析生物感测器的开发。
  • DexCom 对 Oura Ring 的投资标誌着消费性穿戴装置与血糖监测融合迈出了重要一步。
  • 美敦力和微软 Azure 扩大了合作伙伴关係，利用生物感测器数据进行即时心臟风险分析。
  • 美国国家科学基金会 (NSF) 向宾州州立大学颁发了 150 万美元奖金，用于生物感测器创新。
  • Trinity Biotech 和拜耳合作开发适用于印度和中国的连续血糖监测 (CGM)。
  • 荷兰皇家飞利浦和 SmartQare 正在合作开发一套持续远端监测系统。
  • 安德森生物科技公司获得 360 万美元融资，用于扩展其基于感测器的健康技术。
  • 瑞典新创公司 Aligned Bio 获得了欧盟支持的种子轮融资，用于其单分子生物感测器平台的研发。

关键成长动力

即时诊断的扩展

医疗保健的去中心化正在推动生物感测器的应用，68% 的医疗保健提供者正在投资基于生物感测器的诊断技术，以缩短週转时间。从流感检测（现在只需 12 分钟即可完成）到心肌肌钙蛋白检测（从 6 小时缩短至 10 分钟），对即时结果的迫切需求正在重塑全球医疗保健工作流程。

微型化，实现持续监测

尺寸小于 0.5 毫米的可植入生物感测器市场正在蓬勃发展，这些感测器能够即时追踪体内的生物标记。经 FDA 批准的设备，例如雅培的植入式连续血糖监测 (CGM) 和美敦力的心律不整检测器，已被证明可以显着减少紧急住院治疗。石墨烯和边缘运算正在为预测分析和早期干预奠定基础。

新兴科技趋势

  • 石墨烯生物感测器目前可侦测浓度为 0.001 ng/mL 的癌症标记物，比传统检测方法快 85%。
  • 整合人工智慧后，诊断准确率提高了 18%，可识别出 92% 的先前未检测到的病例。
  • 亚太地区在生物感测器应用方面处于领先地位，印度和中国等国家正在迅速扩大连续血糖监测 (CGM) 和即时诊断系统的部署，尤其是在农村地区和老龄化社会。
  • 农业技术领域也涌现许多技术创新，中国有 180 万个农场使用生物感测器进行土壤和农药监测。

本报告分析了全球生物感测器市场，提供了每个细分市场的市场规模和预测、市场动态和趋势以及公司概况。

目录

第1章 调查架构

  • 调查目的
  • 产品概要
  • 市场区隔

第2章 调查手法

第3章 摘要整理:全球生物感应器市场

第4章 全球生物感应器市场概要

  • 产业价值链分析
    • 材料供应商
    • 厂商
    • 批发商
    • 终端用户
  • 产业预测
    • 慢性疾病发生统计
    • 电力诊断设备的进出口资料
  • 大环境分析
  • 波特的五力分析
  • 市场动态和趋势
    • 成长促进因素
    • 阻碍因素
    • 课题
    • 主要趋势
  • 市场成长及预测
    • 市场收益的估计与预测(2020年～2033年)
    • 市场规模的估计与预测(2020年～2033年)
    • 价格趋势的分析
  • 竞争仪表板
    • 市场集中率
    • 企业的市场占有率分析(金额)(2024年)
    • 竞争製图

第5章 全球酵素为基础的生物感应器市场概要

    • 各酵素类型
    • 各用途

第6章 全球生物感应器市场分析:各类型

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 感测器贴片
    • 嵌入式设备

第7章 全球生物感应器市场分析:各产品

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 穿戴式生物感应器
    • 非穿戴式生物感应器

第8章 全球生物感应器市场分析:各技术

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 电化学
    • 物理学
    • 光学

第9章 全球生物感应器市场分析:各用途

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 医疗
    • 食品毒性
    • 生物反应器
    • 农业
    • 环境
    • 研究开发
    • 保全·生化防御
    • 其他

第10章 生物感应器市场分析:各终端用户

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 医疗·诊断
    • 食品·饮料
    • 製药
    • 农业
    • 化妆品
    • 环境
    • 其他

第11章 全球生物感应器市场分析:各地区

  • 重要的知识见解
  • 市场规模与预测(2019年～2032年)
    • 北美
    • 欧洲
    • 亚太地区
    • 中东·非洲
    • 南美

第12章 北美的生物感应器市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 各类型
    • 各产品
    • 各技术
    • 各用途
    • 各终端用户
    • 各国

第13章 欧洲的生物感应器市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 各类型
    • 各产品
    • 各技术
    • 各用途
    • 各终端用户
    • 各国

第14章 亚太地区的生物感应器市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 各类型
    • 各产品
    • 各技术
    • 各用途
    • 各终端用户
    • 各国

第15章 中东·非洲的生物感应器市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 各类型
    • 各产品
    • 各技术
    • 各用途
    • 各终端用户
    • 各国

第16章 南美的生物感应器市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2033年)
    • 各类型
    • 各产品
    • 各技术
    • 各用途
    • 各终端用户
    • 各国

第17章 企业简介(企业概要，财务矩阵，主要的产品的形势，主要人员，主要的竞争，联络处，事业策略预测)

  • 生物感应器厂商
    • Bio-Rad Laboratories Inc.
    • Biosensors International Group, Ltd.
    • Pinnacle Technologies Inc.
    • Johnson & Johnson
    • Koninklijke Philips N.V.
    • DuPont
    • Molecular Devices Corp.
    • Bayer
    • Molex LLC
    • TDK Corp.
    • Seimens
    • Nova Biomedical
    • LifeScan, Inc.
    • 其他的着名的企业
  • 酵素生物感应器厂商
    • Medtronic
    • Abbott Laboratories
    • Roche
    • DirectSens GmbH
    • Zimmer & Peacock AS
    • 其他的着名的企业

第18章 附录

简介目录
Product Code: AA04251266

The global biosensors market is undergoing a significant transformation, fueled by technological advancements and expanding applications across healthcare, environmental monitoring, agriculture, and food safety. Valued at US$ 32.15 billion in 2024, the market is expected to reach US$ 75.84 billion by 2033, reflecting a strong CAGR of 10.40% over the forecast period of 2025-2033.

Biosensors are playing a pivotal role in addressing the growing burden of chronic diseases. With over 422 million people worldwide living with diabetes, continuous glucose monitoring systems have become standard practice, notably Abbott's FreeStyle Libre, which serves 4 million users in the U.S. Similarly, cardiovascular applications are witnessing a revolution through biosensors capable of detecting cardiac biomarkers within minutes, expediting treatment and diagnosis. The adoption of biosensor-integrated wearables among 58 million U.S. users is improving emergency responsiveness and patient outcomes, while cost reductions of 35% since 2020 and smartphone compatibility have made biosensor technologies more accessible.

Beyond healthcare, biosensors are making headway in environmental safety-detecting water contaminants in seconds-and in food safety, where rapid pathogen identification now takes under 15 minutes. Innovations such as graphene-based nanosensors and AI-driven diagnostics are enhancing accuracy, speed, and integration capabilities across sectors.

Noteworthy Market Developments

  • Biolinq raised $100 million in Series C to advance multi-analyte biosensor development.
  • DexCom's investment in Oura Ring marks a major step toward merging consumer wearables with glucose monitoring.
  • Medtronic and Microsoft Azure extended their partnership for real-time cardiac risk analytics via biosensor data.
  • The U.S. NSF awarded $1.5 million to Penn State for biosensor innovation.
  • Trinity Biotech and Bayer partnered to develop CGMs for India and China.
  • Royal Philips and SmartQare co-developing continuous remote monitoring systems.
  • Andson Biotech secured $3.6 million to expand sensor-based health technologies.
  • Aligned Bio, a Swedish startup, attracted EU-backed seed funding for single-molecule biosensor platforms.

Core Growth Drivers

Point-of-Care Diagnostics Expansion:

The decentralization of healthcare is propelling biosensor deployment, with 68% of healthcare providers investing in biosensor-based diagnostics to reduce turnaround times. From flu testing (now done in 12 minutes) to cardiac troponin detection (from 6 hours to 10 minutes), the urgency for immediate results is reshaping medical workflows globally.

Miniaturization for Continuous Monitoring:

The market is witnessing a surge in implantable biosensors under 0.5 mm in size, allowing real-time tracking of internal biomarkers. FDA-approved devices like Abbott's implantable CGM and Medtronic's arrhythmia detectors are proving to significantly reduce emergency hospitalizations. Graphene and edge computing are setting the stage for predictive analytics and early intervention.

Emerging Technology Trends

  • Graphene biosensors now detect cancer markers at 0.001 ng/mL-85% faster than conventional tests.
  • AI integration is improving diagnostic accuracy by 18%, identifying 92% of previously undetected cases.
  • Asia-Pacific leads in biosensor adoption, especially in rural and aging populations, with countries like India and China rapidly expanding CGM and point-of-care deployment.
  • Innovations are also emerging in agri-tech, with 1.8 million farms in China using biosensors for soil and pesticide monitoring.

Barriers to Optimization

Regulatory Bottlenecks:

Stringent global regulatory frameworks continue to delay biosensor commercialization. In the U.S., average FDA approval timelines have lengthened to 17 months, while Europe's MDR mandates extended post-market surveillance. Additional burdens include mandatory in-country trials in China and cybersecurity regulations. Startups often face budgetary constraints, spending up to 35% of resources on trial redesigns due to changing ISO requirements.

Detailed Market Segmentation

By Technology:

Electrochemical biosensors dominate with over 71% market share in 2025. Used across diabetes management (CGMs), cardiovascular diagnostics (troponin-I), environmental monitoring (lead detection), and pharma R&D, their accuracy and adaptability make them the cornerstone of biosensor adoption. Platforms like Siemens Healthineers' S100 sepsis detector and India's $20 TB detection chips exemplify their utility.

By End Users:

Healthcare laboratories and clinics account for 51.7% of the market. Adoption of biosensors for EGFR, PD-L1, MRSA, VRE, and rapid sepsis detection is on the rise. India's Ayushman Bharat initiative and the CLIA-waived U.S. primary care mandate are key growth enablers.

By Type:

Embedded biosensors lead with 72.47% share, favored in dialysis systems, insulin pumps, and biopharma QA. Applications in RPM, telemedicine, automotive safety (e.g., alcohol sensors), and Industry 4.0 manufacturing underline their expansive integration.

By Product Type:

Non-wearable biosensors constitute 60.08% of the market, driven by their accuracy in clinical settings-blood-gas analyzers, cardiac monitors, pregnancy tests, and food safety detectors like ATP swabs. Their precision remains unmatched in critical care and regulated environments.

Geographic Insights

North America

North America dominates with 44.61% share, led by the U.S., which alone contributed 41% in 2024. With a strong R&D pipeline, widespread CGM adoption, and a booming wearables sector, the U.S. biosensors market continues to flourish. Key growth areas include POC testing, chronic disease monitoring, and venture-backed startups like Biolinq.

Europe

Europe contributes 28.3% to global revenue. EMA's proactive stance and funding programs like Horizon Europe and Health Innovation 2030 are fueling AI-driven sensor innovation. Countries such as Germany, France, and the U.K. are pioneering advanced biosensor trials and integration into public health frameworks.

Asia-Pacific

The region holds 19.8% share and is growing rapidly. CGM sales in China and India are spiking due to high diabetes prevalence. Government programs like Ayushman Bharat and NMPA's rapid approvals are facilitating rural and urban market penetration. Startups in Vietnam and Indonesia are spearheading affordable diagnostics.

Leading Market Participants

  • Bio-Rad Laboratories Inc.
  • Biosensors International Group, Ltd.
  • Pinnacle Technologies Inc.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • DuPont
  • Molecular Devices Corp.
  • Bayer
  • Molex LLC
  • TDK Corp.
  • Seimens
  • Nova Biomedical
  • LifeScan, Inc.
  • Medtronic
  • Abbott Laboratories
  • Roche
  • DirectSens GmbH
  • Zimmer & Peacock AS
  • Other Prominent Players

Comprehensive Segmentation Framework

By Type

  • Sensor Patch
  • Embedded Device

By Product

  • Wearable Biosensors
  • Non-Wearable Biosensors

By Technology

  • Electrochemical
  • Amperometric
  • Potentiometric
  • Voltammetric
  • Others
  • Physical
  • Piezoelectric
  • Thermometric
  • Optical

By Application

  • Medical
  • POC Testing
  • Cholesterol
  • Blood Glucose
  • Blood Gas Analyzer
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease
  • Bioreactor
  • Agriculture
  • Environment
  • Research & Development
  • Security and Bio-Defense
  • Others

By End User

  • Healthcare & Diagnostics
  • Food and Beverage
  • Pharmaceutical
  • Agriculture
  • Cosmetics
  • Environmental
  • Others

By Region:

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia & New Zealand
  • ASEAN
  • Cambodia
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Table of Content

Chapter 1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

Chapter 2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents, By Region
  • 2.4. Assumption for the Study
  • 2.5. Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global Biosensor Market

Chapter 4. Global Biosensor Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Material Provider
    • 4.1.2. Manufacturer
    • 4.1.3. Distributor
    • 4.1.4. End User
  • 4.2. Industry Outlook
    • 4.2.1. Chronic Disease Incidence Statistics
    • 4.2.2. Electro-diagnostic Devices EXIM Data
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Market Dynamics and Trends
    • 4.5.1. Growth Drivers
    • 4.5.2. Restraints
    • 4.5.3. Challenges
    • 4.5.4. Key Trends
  • 4.6. Market Growth and Outlook
    • 4.6.1. Market Revenue Estimates and Forecast (US$ Bn), 2020-2033
    • 4.6.2. Market Volume Estimates and Forecast (Bn Units), 2020-2033
    • 4.6.3. Price Trend Analysis
  • 4.7. Competition Dashboard
    • 4.7.1. Market Concentration Rate
    • 4.7.2. Company Market Share Analysis (Value %), 2024
    • 4.7.3. Competitor Mapping

Chapter 5. Global Enzyme Based Biosensor Market Overview

    • 5.1.1. By Enzyme Type
      • 5.1.1.1. Key Insights
      • 5.1.1.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
        • 5.1.1.2.1. Oxidoreductases (e.g., glucose oxidase, lactate oxidase)
        • 5.1.1.2.2. Hydrolases (e.g., urease, cholinesterase)
        • 5.1.1.2.3. Transferases
        • 5.1.1.2.4. Lyases
    • 5.1.2. By Application
      • 5.1.2.1. Key Insights
      • 5.1.2.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
        • 5.1.2.2.1. Healthcare
          • 5.1.2.2.1.1. POC Testing
          • 5.1.2.2.1.2. Cholesterol
          • 5.1.2.2.1.3. Blood Glucose
          • 5.1.2.2.1.4. Blood Gas Analyzer
          • 5.1.2.2.1.5. Pregnancy Testing
          • 5.1.2.2.1.6. Drug Discovery
          • 5.1.2.2.1.7. Infectious Disease
          • 5.1.2.2.1.8. Cancer Biomarker Detection
        • 5.1.2.2.2. Cosmetics
          • 5.1.2.2.2.1. Enzyme-based skincare products
          • 5.1.2.2.2.2. Anti-aging formulations

Chapter 6. Global Biosensor Market Analysis, By Type

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 6.2.1. Sensor Patch
    • 6.2.2. Embedded Device

Chapter 7. Global Biosensor Market Analysis, By Product

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 7.2.1. Wearable Biosensors
    • 7.2.2. Non-Wearable Biosensors

Chapter 8. Global Biosensor Market Analysis, By Technology

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 8.2.1. Electrochemical
      • 8.2.1.1. Amperometric
      • 8.2.1.2. Potentiometric
      • 8.2.1.3. Voltammetric
      • 8.2.1.4. Others
    • 8.2.2. Physical
      • 8.2.2.1. Piezoelectric
      • 8.2.2.2. Thermometric
    • 8.2.3. Optical

Chapter 9. Global Biosensor Market Analysis, By Application

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 9.2.1. Medical
      • 9.2.1.1. POC Testing
      • 9.2.1.2. Cholesterol
      • 9.2.1.3. Blood Glucose
      • 9.2.1.4. Blood Gas Analyzer
      • 9.2.1.5. Pregnancy Testing
      • 9.2.1.6. Drug Discovery
      • 9.2.1.7. Infectious Disease
    • 9.2.2. Food Toxicity
    • 9.2.3. Bioreactor
    • 9.2.4. Agriculture
    • 9.2.5. Environment
    • 9.2.6. Research & Development
    • 9.2.7. Security and Bio-Defense
    • 9.2.8. Others

Chapter 10. Global Biosensor Market Analysis, By End User

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 10.2.1. Healthcare & Diagnostics
    • 10.2.2. Food and Beverage
    • 10.2.3. Pharmaceutical
    • 10.2.4. Agriculture
    • 10.2.5. Cosmetics
    • 10.2.6. Environmental
    • 10.2.7. Others

Chapter 11. Global Biosensor Market Analysis, By Region

  • 11.1. Key Insights
  • 11.2. Market Size and Forecast, 2019 - 2032 (US$ Bn & Bn Units)
    • 11.2.1. North America
      • 11.2.1.1. The U.S.
      • 11.2.1.2. Canada
      • 11.2.1.3. Mexico
    • 11.2.2. Europe
      • 11.2.2.1. Western Europe
        • 11.2.2.1.1. The UK
        • 11.2.2.1.2. Germany
        • 11.2.2.1.3. France
        • 11.2.2.1.4. Italy
        • 11.2.2.1.5. Spain
        • 11.2.2.1.6. Rest of Western Europe
      • 11.2.2.2. Eastern Europe
        • 11.2.2.2.1. Poland
        • 11.2.2.2.2. Russia
        • 11.2.2.2.3. Rest of Eastern Europe
    • 11.2.3. Asia Pacific
      • 11.2.3.1. China
      • 11.2.3.2. India
      • 11.2.3.3. Japan
      • 11.2.3.4. South Korea
      • 11.2.3.5. Australia & New Zealand
      • 11.2.3.6. ASEAN
        • 11.2.3.6.1. Cambodia
        • 11.2.3.6.2. Indonesia
        • 11.2.3.6.3. Malaysia
        • 11.2.3.6.4. Philippines
        • 11.2.3.6.5. Singapore
        • 11.2.3.6.6. Thailand
        • 11.2.3.6.7. Vietnam
      • 11.2.3.7. Rest of Asia Pacific
    • 11.2.4. Middle East & Africa
      • 11.2.4.1. UAE
      • 11.2.4.2. Saudi Arabia
      • 11.2.4.3. South Africa
      • 11.2.4.4. Rest of MEA
    • 11.2.5. South America
      • 11.2.5.1. Argentina
      • 11.2.5.2. Brazil
      • 11.2.5.3. Rest of South America

Chapter 12. North America Biosensor Market Analysis

  • 12.1. Key Insights
  • 12.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 12.2.1. By Type
    • 12.2.2. By Product
    • 12.2.3. By Technology
    • 12.2.4. By Application
    • 12.2.5. By End User
    • 12.2.6. By Country

Chapter 13. Europe Biosensor Market Analysis

  • 13.1. Key Insights
  • 13.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 13.2.1. By Type
    • 13.2.2. By Product
    • 13.2.3. By Technology
    • 13.2.4. By Application
    • 13.2.5. By End User
    • 13.2.6. By Country

Chapter 14. Asia Pacific Biosensor Market Analysis

  • 14.1. Key Insights
  • 14.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 14.2.1. By Type
    • 14.2.2. By Product
    • 14.2.3. By Technology
    • 14.2.4. By Application
    • 14.2.5. By End User
    • 14.2.6. By Country

Chapter 15. Middle East & Africa Biosensor Market Analysis

  • 15.1. Key Insights
  • 15.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 15.2.1. By Type
    • 15.2.2. By Product
    • 15.2.3. By Technology
    • 15.2.4. By Application
    • 15.2.5. By End User
    • 15.2.6. By Country

Chapter 16. South America Biosensor Market Analysis

  • 16.1. Key Insights
  • 16.2. Market Size and Forecast, 2020-2033 (US$ Bn & Bn Units)
    • 16.2.1. By Type
    • 16.2.2. By Product
    • 16.2.3. By Technology
    • 16.2.4. By Application
    • 16.2.5. By End User
    • 16.2.6. By Country

Chapter 17. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 17.1. Biosensor Manufacturers
    • 17.1.1. Bio-Rad Laboratories Inc.
    • 17.1.2. Biosensors International Group, Ltd.
    • 17.1.3. Pinnacle Technologies Inc.
    • 17.1.4. Johnson & Johnson
    • 17.1.5. Koninklijke Philips N.V.
    • 17.1.6. DuPont
    • 17.1.7. Molecular Devices Corp.
    • 17.1.8. Bayer
    • 17.1.9. Molex LLC
    • 17.1.10. TDK Corp.
    • 17.1.11. Seimens
    • 17.1.12. Nova Biomedical
    • 17.1.13. LifeScan, Inc.
    • 17.1.14. Other Prominent Players
  • 17.2. Enzyme Biosensors Manufacturers
    • 17.2.1. Medtronic
    • 17.2.2. Abbott Laboratories
    • 17.2.3. Roche
    • 17.2.4. DirectSens GmbH
    • 17.2.5. Zimmer & Peacock AS
    • 17.2.6. Other Prominent Players

Chapter 18. Annexure

  • 18.1. List of Secondary Sources
  • 18.2. Key Country Markets - Marco Economic Outlook/Indicators